Human umbilical cord perivascular cells exhibit enhanced cardiomyocyte reprogramming and cardiac function after experimental acute myocardial infarction

Cell Transplantation

Volumn 22, Issue 9, 2013, Pages 1651-1666

  Yannarelli, Gustavo ^a   Dayan, Victor ^a   Pacienza, Natalia ^b   Lee, Chyan Jang ^b   Medin, Jeffrey ^b   Keating, Armand ^a,c  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cardiomyocyte differentiation; Cell therapy; Human umbilical cord perivascular cells (HUCPVCs); Mesenchymal stromal cells (MSCs)

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; MYOCYTE ENHANCER FACTOR 2; MYOSIN HEAVY CHAIN ALPHA; TRANSCRIPTION FACTOR GATA 4;

ACUTE HEART INFARCTION; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL REGENERATION; CELL THERAPY; CELL TYPE; COCULTURE; CONTROLLED STUDY; EMBRYO; EMBRYO CELL; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART FUNCTION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN UMBILICAL CORD PERIVASCULAR CELL; MALE; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; SCID MOUSE; TISSUE REGENERATION; UMBILICAL CORD; UPREGULATION;

ADULT; ANIMALS; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED NOD; MICE, SCID; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; NUCLEAR REPROGRAMMING; RATS; UMBILICAL CORD; YOUNG ADULT;

EID: 84883532879     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X657675     Document Type: Article

References (57)

1. Amado, L. C; Saliaris, A. P.; Schuleri, K. H.; St John, M.; Xie, J. S.; Cattaneo, S.; Durand, D. J.; Fitton, T.; Kuang, J. Q.; Stewart, G.; Lehrke, S.; Baumgartner, W. W.; Martin, B. J.; Heldman, A. W.; Hare, J. M. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc. Natl. Acad. Sci. USA 102:11474-11479; 2005.
2. Amado, L. C; Schuleri, K. H.; Saliaris, A. P.; Boyle, A. J.; Helm, R.; Oskouei, B.; Centola, M.; Eneboe, V.; Young, R.; Lima, J. A.; Lardo, A. C; Heldman, A. W.; Hare, J. M. Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy. J. Am. Coll. Cardiol. 48:2116-2124; 2006.
3. Amendola, M.; Venneri, M. A.; Biffi, A.; Vigna, E.; Naldini, L. Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters. Nat. Biotechnol. 23:108-116; 2005.
4. Arminãn, A.; Gandía, C; Bartual, M.; Garcia-Verdugo, J. M.; Lledó, E.; Mirabet, V.; Llop, M.; Barea, J.; Montero, J. A.; Sepulveda, P. Cardiac differentiation is driven by NKX2.5 and GATA4 nuclear translocation in tissue-specific mesenchymal stem cells. Stem Cells Dev. 18:907-918; 2009.
5. Behfar, A.; Yamada, S.; Crespo-Diaz, R.; Nesbitt, J. J.; Rowe, L. A.; Perez-Terzic, C; Gaussin, V.; Homsy, C; Bartunek, J.; Terzic, A. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J. Am. Coll. Cardiol. 56:721-734; 2010.
6. Bouffi, C; Bony, C; Courties, G.; Jorgensen, C; Noel, D. IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis. PLoS One 5:el4247; 2010.
7. Christensen, M. E.; Turner, B. E.; Sinfield, L. J.; Kollar, K.; Cullup, H.; Waterhouse, N. J.; Hart, D. N.; Atkinson, K.; Rice, A. M. Mesenchymal stromal cells transiently alter the inflammatory milieu post-transplant to delay graft-versus-host disease. Haematologica 95:2102-2110; 2010.
8. Dai, W.; Hale, S. L.; Martin, B. J.; Kuang, J. Q.; Dow, J. S.; Wold, L. E.; Kloner, R. A. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: Short-and long-term effects. Circulation 112:214-223; 2005.
9. Davani, S.; Marandin, A.; Mersin, N.; Royer, B.; Kantelip, B.; Hervé, P.; Etievent, J. P.; Kantelip, J. P. Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation 108(Suppl 1): 0253-11258; 2003.
10. Dayan, V.; Yannarelli, G.; Billia, E; Filomeno, P.; Wang, X. H.; Davies, J. E.; Keating, A. Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/ macrophages after acute myocardial infarction. Basic Res. Cardiol. 106:1299-1310; 2011.
11. Dominici, M.; Le Blanc, K; Mueller, I.; Slaper-Cortenbach, I.; Marini, E; Krause, D.; Deans, R.; Keating, A.; Prockop, D. J.; Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317; 2006.
12. Ennis, J.; Sarugaser, R.; Gomez, A.; Baksh, D.; Davies, J. E. Isolation, characterization, and differentiation of human umbilical cord perivascular cells (HUCPVCs). Methods CellBiol. 86:121-136; 2008.
13. Fan, M.; Chen, W; Liu, W.; Du, G. Q.; Jiang, S. L.; Tian, W C; Sun, L.; Li, R. K; Tian, H. The effect of age on the efficacy of human mesenchymal stem cell transplantation after a myocardial infarction. Rejuvenation Res. 13:429-38; 2010.
14. Gaebel, R.; Furlani, D.; Sorg, H.; Polchow, B.; Frank, J.; Bieback, K.; Wang, W.; Klopsch, C; Ong, L. L.; Li, W.; Ma, N.; Steinhoff, G. Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration. PLoS One 6:el5652; 2011.
15. Ge, D.; Liu, X.; Li, L.; Wu, J.; Tu, Q.; Shi, Y.; Chen, H. Chemical and physical stimuli induce cardiomyocyte differentiation from stem cells. Biochem. Biophys. Res. Commun. 381:317-321; 2009.
16. Gersh, B. J.; Simari, R. D.; Behfar, A.; Terzic, C. M.; Terzic, A. Cardiac cell repair therapy: A clinical perspective. Mayo Clin. Proc. 84:876-892; 2009.
17. Gieseke, E; Bohringer, J.; Bussolari, R.; Dominici, M.; Handgretinger, R.; Muller, I. Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells. Blood 116:3770-3779; 2010.
18. Gnecchi, M.; He, H.; Noiseux, N.; Liang, O. D.; Zhang, L.; Morello, E; Mu, H.; Melo, L. G.; Pratt, R. E.; Ingwall, J. S.; Dzau, V. J. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 20:661-669; 2006.
19. Griffin, M. D.; Ritter, T.; Mahon, B. P. Immunological aspects of allogeneic mesenchymal stem cell therapies. Hum. Gene Then 21:1641-1655; 2010.
20. Gruh, I.; Wunderlich, S.; Winkler, M.; Schwanke, K; Heinke, J.; Blomer, U.; Ruhparwar, A.; Rohde, B.; Li, R. K; Haverich, A.; Martin, U. Human CMV immediate-early enhancer: A useful tool to enhance cell-type-specific expression from lentiviral vectors. J. Gene Med. 10:21-32; 2008.
21. Halkos, M. E.; Zhao, Z. Q.; Kerendi, E; Wang, N. P.; Jiang, R.; Schmarkey, L. S.; Martin, B. J.; Quyyumi, A. A.; Few, W. L.; Kin, H.; Guyton, R. A.; Vinten-Johansen, J. Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction. Basic Res. Cardiol. 103:525-536; 2008.
22. Hatzistergos, K. E.; Quevedo, H.; Oskouei, B. N.; Hu, Q.; Feigenbaum, G. S.; Margitich, I. S.; Mazhari, R.; Boyle, A. J.; Zambrano, J. P.; Rodriguez, J. E.; Dulce, R.; Pattany, P. M.; Valdes, D.; Revilla, C; Heldman, A. W.; McNiece, I.; Hare, J. M. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ. Res. 107:913-922; 2010.
23. Hermann, A.; List, C; Habisch, H. J.; Vukicevic, V.; Ehrhart-Bornstein, M.; Brenner, R.; Bernstein, P.; Fickert, S.; Storch, A. Age-dependent neuroectodermal differentiation capacity of human mesenchymal stromal cells: Limitations for autologous cell replacement strategies. Cytotherapy 12:17-30; 2010.
24. Ieda, M.; Fu, J. D.; Delgado-Olguin, P.; Vedantham, V.; Hayashi, Y.; Bruneau B. G.; Srivastava, D. Direct repro-gramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142:375-386; 2010.
25. Jones, P. A.; Taylor, S. M. Cellular differentiation, cytidine analogs and DNAmethylation. Cell 20:85-93; 1980.
26. Kasper, G.; Dankert, N.; Tuischer, J.; Hoeft, M.; Gaber, T.; Glaeser, J. D.; Zander, D.; Tschirschmann, M.; Thompson, M.; Matziolis, G.; Duda, G. N. Mesenchymal stem cells regulate angiogenesis according to their mechanical environment. Stem Cells 25:903-910; 2007.
27. Khan, M.; Mohsin, S.; Khan, S. N.; Riazuddin, S. Repair of senescent myocardium by mesenchymal stem cells is dependent on the age of donor mice. J. Cell. Mol. Med. 15:1515-1527; 2011.
28. Kocher, A. A.; Schuster, M. D.; Szabolcs, M. J.; Takuma, S.; Burkhoff, D.; Wang, J.; Homma, S.; Edwards, N. M.; Itescu, S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardio-myocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7:430-136; 2001.
29. Koninckx, R.; Hensen, K.; Daniels, A.; Moreels, M.; Lambrichts, I.; Jongen, H.; Clysters, C; Mees, U.; Steels, P.; Hendrikx, M.; Rummens, J. L. Human bone marrow stem cells co-cultured with neonatal rat cardiomyocytes display limited cardiomyogenic plasticity. Cytotherapy 11:778-792; 2009.
30. Labovsky, V.; Hofer, E. L.; Feldman, L.; Fernandez Vallone, V.; Garcia Rivello, H.; Bayes-Genis, A.; Hernando Insua, A.; Levin, M. J.; Chasseing, N. A. Cardiomyogenic differentiation of human bone marrow mesenchymal cells: Role of cardiac extract from neonatal rat cardiomyocytes. Differentiation 79:93-101; 2010.
31. Lee, R. H.; Pulin, A. A.; Seo, M. J.; Kota, D. J.; Ylostalo, L; Larson, B. L.; Semprun-Prieto, L.; Delafontaine, P.; Prockop, D. J. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5:54-63; 2009.
32. Li, S. H.; Lai, T. Y.; Sun, Z.; Han, M.; Moriyama, E.; Wilson, B.; Fazel, S.; Weisel, R. D.; Yau, T.; Wu, J. C; Li, R. K. Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery. J. Thorac. Cardiovasc. Surg. 137:1225-1233; 2009.
33. Lin, Q.; Schwarz, J.; Bucana, C; Olson, E. N. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276:1404-1407; 1997.
34. Lipinski, M. J.; Biondi-Zoccai, G. G; Abbate, A.; Khianey, R.; Sheiban, I.; Bartunek, J.; Vanderheyden, M.; Kim, H. S.; Kang, H. J.; Strauer, B. E.; Vetrovec, G. W. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: A collaborative systematic review and meta-analysis of controlled clinical trials. J. Am. Coll. Cardiol. 50:1761-1767; 2007.
35. Livak, K. J.; Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2[-Delta Delta C(T)] method. Methods 25:402-408; 2001.
36. Lloyd-Jones, D.; Adams, R.; Carnethon, M.; De Simone, G.; Ferguson, T. B.; Flegal, K.; Ford, E.; Furie, K.; Go, A.; Greenlund, K.; Haase, N.; Hailpern, S.; Ho, M.; Howard, V.; Kissela, B.; Kittner, S.; Lackland, D.; Lisabeth, L.; Marelli, A.; McDermott, M.; Meigs, J.; Mozaffarian, D.; Nichol, G; O'Donnell, C; Roger, V.; Rosamond, W.; Sacco, R.; Sorlie, P.; Stafford, R.; Steinberger, J.; Thorn, T; Wasserthiel-Smoller, S.; Wong, N.; Wylie-Rosett, J.; Hong, Y.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119:480-486; 2009.
37. Lu, L. L.; Liu, Y J.; Yang, S. G; Zhao, Q. J.; Wang, X.; Gong, W.; Han, Z. B.; Xu, Z. S.; Lu, Y. X.; Liu, D.; Chen, Z. Z.; Han, Z. C. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 91: 1017-1026; 2006.
38. Martin-Rendon, E.; Sweeney, D.; Lu, F.; Girdlestone, J.; Navarrete, C; Watt S. M. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. Vox Sang. 95:137-148; 2008.
39. Morin, S.; Charron, E; Robitaille, L.; Nemer, M. GATA-dependent recruitment of MEF2 proteins to target promoters. EMBO J. 19:2046-2055; 2000.
40. Nahrendorf, M.; Swirski, F. K.; Aikawa, E.; Stangenberg, L.; Wurdinger, T; Figueiredo, J. L.; Libby, P.; Weissleder, R.; Pittet, M. J. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 204:3037-3047; 2007.
41. Noiseux, N.; Gnecchi, M.; Lopez-Ilasaca, M.; Zhang, L.; Solomon, S. D.; Deb, A.; Dzau, V. J.; Pratt, R. E. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol. Then 14:840-850; 2006.
42. Prat-Vidal, C; Roura, S.; Farré, J.; Gålvez, C; Llach, A.; Molina, C. E.; Hove-Madsen, L.; Garcia, J.; Cinca, J.; Bayes-Genis, A. Umbilical cord blood-derived stem cells spontaneously express cardiomyogenic traits. Transplant. Proc. 39:2434-2437; 2007.
43. Psaltis, P. J.; Paton, S.; See, E.;Arthur, A.; Martin, S.; Itescu, S.; Worthley, S. G.; Gronthos, S.; Zannettino, A. C. Enrichment for STRO-1 expression enhances the cardiovascular para-crine activity of human bone marrow-derived mesenchymal cell populations. J. Cell. Physiol. 223:530-540; 2010.
44. Psaltis, P. J.; Zannettino, A. C; Worthley, S. G; Gronthos, S. Concise review: Mesenchymal stromal cells: Potential for cardiovascular repair. Stem Cells 26:2201-2210; 2008.
45. Qian, Q.; Qian, H.; Zhang, X.; Zhu, W.; Yan, Y; Ye, S.; Peng, X.; Li, W; Xu, Z.; Sun, L.; Xu, W. 5-Azacytidine induces cardiac differentiation of human umbilical cord-derived mesenchymal stem cells by activating extracellular regulated kinase. Stem Cells Dev. 21:67-75; 2012.
46. Ranganath, S. H.; Levy, O.; Inamdar, M. S.; Karp, J. M. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 10:244-258; 2012.
47. Reinecke, H.; Minami, E.; Zhu, W. Z.; Laflamme, M. A. Cardiogenic differentiation and transdifferentiation of progenitor cells. Circ. Res. 103:1058-1071; 2008.
48. Rose, R. A.; Jiang, H.; Wang, X.; Helke, S.; Tsoporis, J. N.; Gong, N.; Keating, S. C; Parker, T. G.; Backx, P. H.; Keating, A. Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro. Stem Cells 26:2884-2892; 2008.
49. Roura, S.; Farré, J.; Hove-Madsen, L.; Prat-Vidal, C; Soler-Botija, C; Gålvez-Montön, C; Vilalta, M.; Bayes-Genis, A. Exposure to cardiomyogenic stimuli fails to transdiffer-entiate human umbilical cord blood-derived mesenchymal stem cells. Basic Res. Cardiol. 105:419-130; 2010.
50. Sarugaser, R.; Hanoun, L.; Keating, A.; Stanford, W. L.; Davies, J. E. Human mesenchymal stem cells self-renew and differentiate according to a deterministic hierarchy. PLoS One 4:e6498; 2009.
51. Sarugaser, R.; Lickorish, D.; Baksh, D.; Hosseini, M. M.; Davies, J. E. Human umbilical cord perivascular (HUCPV) cells: A source of mesenchymal progenitors. Stem Cells 23:220-229; 2005.
52. Tarnavski, O.; McMullen, J. R.; Schinke, M.; Nie, Q.; Kong, S.; Izumo, S. Mouse cardiac surgery: Comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies. Physiol. Genomics 16:349-360; 2004.
53. Timmers, L.; Lim, S. K; Hoefer, I. E.; Arslan, E; Lai, R. C; van Oorschot, A. A.; Goumans, M. J.; Strijder, C; Sze, S. K; Choo, A.; Piek, J. J.; Doevendans P. A.; Pasterkamp, G.; de Kleijn, D. P. Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem Cell Res. 6:206-214; 2011.
54. Waldenstrom, A.; Gennebäck, N.; Hellman, U.; Ronquist, G. Cardiomyocyte microvesicles contain DNA/RNA and convey biological messages to target cells. PLoS One 7:e34653; 2012.
55. Wu, K H.; Mo, X. M.; Zhou, B.; Lu, S. H.; Yang, S. G.; Liu, Y L.; Han, Z. C. Cardiac potential of stem cells from whole human umbilical cord tissue. J. Cell. Biochem. 107:926-932; 2009.
56. Yoon, C. H.; Koyanagi, M.; lekushi, K; Seeger, E; Urbich, C; Zeiher, A. M.; Dimmeler, S. Mechanism of improved cardiac function after bone marrow mononuclear cell therapy: Role of cardiovascular lineage commitment. Circulation 121:2001-2011; 2010.
57. Yoshimitsu, M.; Sato, T.; Tao, K; Walia, J. S.; Rasaiah, V. I.; Sleep, G. T.; Murray, G. J.; Poeppl, A. G.; Underwood, J.; West, L.; Brady, R. O.; Medin, J. A. Bioluminescent imaging of a marking transgene and correction of Fabry mice by neonatal injection of recombinant lentiviral vectors. Proc. Natl. Acad. Sci. USA 101:16909-16914; 2004.